The government has repealed Wednesday, the derogation provisions authorizing the prescription of hydroxychloroquine against the Covid-19 in a hospital in France, outside clinical trials, following an unfavourable opinion of the High Council of public health, according to a decree in the official Journal.
Since the end of march, hydroxychloroquine, a drug derived from the antimalarial chloroquine, could be prescribed as derogatory to the hospital and only for seriously ill patients, on collegial decision making of doctors.
Consult our folder : Coronavirus : the world stop
